ANNELLE DUGAS: Open Payments
NPI 1831555002 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 47 payments from 16 companies in 2025. Trend: 2023 $1,016 · 2024 $745 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $270 |
| Janssen Biotech, Inc. | 9 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $137 |
| COLOPLAST CORP | 2 | $41 |
| Dendreon Pharmaceuticals LLC | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| UROGEN PHARMA, INC. | 1 | $24 |
| 180 Medical, Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $21 |
Products named: ERLEADA, GEMTESA, Nubeqa, ORGOVYX, PROVENGE, KEYTRUDA, GENTLECATH GLIDE, Exparel.
Industry payments across MS — which companies pay providers there.
